Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crucell Holland BvfiledCriticalCrucell Holland Bv
Publication of AR095869A1publicationCriticalpatent/AR095869A1/en
Anticuerpos aislados y fragmentos de unión al antígeno que se unen a la proteína G del RSV (Virus Sincicial Respiratorio) y que tienen la capacidad para neutralizar los subtipos A y B del RSV, y su uso en el diagnóstico, la profilaxis y/o el tratamiento de infecciones por RSV. Ácido nucleico, vector, célula huésped, método de producción y composición farmacéutica.Isolated antibodies and antigen-binding fragments that bind to RSV G protein (Respiratory Syncytial Virus) and that have the ability to neutralize RSV subtypes A and B, and their use in diagnosis, prophylaxis and / or RSV infection treatment. Nucleic acid, vector, host cell, production method and pharmaceutical composition.
ARP140101606A2013-04-152014-04-15
HUMAN ANTIBODIES THAT JOIN PROTEIN G OF RSV
AR095869A1
(en)
monoclonal antibodies specifically for human respiratory syncytial virus p antigen produced and secreted by hybridoma cells useful for detection and diagnosis of vsr infection